U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Summary
The U.S. prostate cancer nuclear medicine diagnostics market size was valued at USD 75.06 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. The increasing incidence of prostate cancer continues to be one of the major factors driving the demand for early and...